Ameritas Investment Partners’s Molecular Templates, Inc. MTEM Stock Holding History

Ameritas Investment Partners’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-143	Closed	-$7K	–	3318
2022 Q1	$7K	Hold	143	–	–	﹤0.01%	2909
2021 Q4	$8K	Hold	143	–	–	﹤0.01%	2972
2021 Q3	$14K	Hold	143	–	–	﹤0.01%	2857
2021 Q2	$17K	Hold	143	–	–	﹤0.01%	2826
2021 Q1	$27K	Hold	143	–	–	﹤0.01%	2439
2020 Q4	$20K	Hold	143	–	–	﹤0.01%	2485
2020 Q3	$23K	Hold	143	–	–	﹤0.01%	2310
2020 Q2	$30K	Buy	143 +48	+51%	+$11.2K	﹤0.01%	2143
2020 Q1	$19K	Hold	95	–	–	﹤0.01%	2219
2019 Q4	$20K	Buy	95 +47	+98%	+$6.75K	﹤0.01%	2421
2019 Q3	$5K	Hold	48	–	–	﹤0.01%	2946
2019 Q2	$6K	Hold	48	–	–	﹤0.01%	2933
2019 Q1	$4K	Hold	48	–	–	﹤0.01%	2895
2018 Q4	$3K	Hold	48	–	–	﹤0.01%	2923
2018 Q3	$4K	Hold	48	–	–	﹤0.01%	2973
2018 Q2	$4K	Buy	+48	New	+$5.43K	﹤0.01%	2959

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameritas Investment Partners's MTEM Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 143 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in MTEM in Q2 2018 and held it in 16 quarters. The position peaked at $30K in Q2 2020. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

Ameritas Investment Partners reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 143 Molecular Templates, Inc. shares in Q2 2022, an estimated $7K.
Ameritas Investment Partners first reported a position in Molecular Templates, Inc. in Q2 2018 and held it in 16 quarters.
Ameritas Investment Partners's Molecular Templates, Inc. position peaked at $30K in Q2 2020.
65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.